Your Securities Clause Samples

The "Your Securities" clause defines the rights and responsibilities of the parties regarding any securities, such as stocks or bonds, that are owned or held by the client within the context of the agreement. Typically, this clause clarifies how these securities will be managed, transferred, or safeguarded, and may specify the extent of the client's ownership and control over them. Its core function is to ensure clarity about the treatment and handling of the client's securities, thereby preventing disputes and misunderstandings about ownership or access.
Your Securities. 1. All client assets are held by the Product Provider appointed by us in a nominee account with an approved third party’s custodian. When considering where assets are held the Product Provider will exercise all due skill, care and diligence and will periodically review the adequacy and appropriateness of any custodian where client assets are deposited. Your assets will be pooled with those of other clients, and as a result your holding may not be individually identifiable on the relevant company register. 2. The company that has issued the Securities may from time to time invite holders of their Securities to attend meetings, cast votes, subscribe for additional Securities and/or to take other actions. These are sometimes referred to as “corporate actions”. The registered holder of those Securities (i.e. the Custodian in this case) will be informed of these corporate actions. 3. The Custodian, Product Provider and Orca do not have any obligation to, and will not ordinarily inform you of any such corporate actions. 4. You can request us to send you, for every Security you beneficial hold via our Service, the report and accounts and any other information issued to the Custodian regarding those Securities. We or the Product Provider reserve the right to make a charge to cover the administration cost for facilitating this. 5. If, as the beneficial owner of the Securities, you wish to personally participate in any corporate actions e.g., attend meetings and cast votes, it is your responsibility to keep yourself informed about such corporate actions. If you do want to attend a meeting and cast votes, then on each occasion you can request us to arrange this for you, provided in our opinion there is enough time to make these arrangements. We or the Product Provider reserve the right to make a charge to cover the administrative costs of making these arrangements. 6. If we do not receive a request from you that you wish to participate in a corporate action then you hereby: (i) irrevocably waive your right to exercise any corporate actions that may be exercised by the holder of the Securities that you beneficially own through our Service, and (ii) agree that the Custodian may in its discretion act on those corporate actions as it sees fit (which may include not to take any action at all). 7. To the extent that your Securities entitle the holder thereof to any proceeds (for example, dividends or interest in the form of cash) or to other benefits (for example, Securiti...
View SourceView Similar (4)
Your Securities may not have an active trading market; the aggregate nominal amount of Securities outstanding at anytimemaybe significantly less than that outstanding on the issue date, and this could have a negative impact on your ability to sell your Securities in the secondarymarket
View SourceView Similar (2)
Your Securities. The Custodian that holds Securities that you have acquired through our Services will have legal title to those Securities and will hold those Securities in its name – in other words, the Custodian’s name will appear on all registers, etc. that show who the owner of those Securities is. However, you will be the beneficial owner of those Securities – in other words, as between you, us and the Custodian, you are the ultimate owner of those Securities.
View SourceView Similar (2)
Your Securities. 1. All client assets are held by the Product Provider appointed by us in a nominee account with an approved third party’s custodian. When considering where assets are held the Product Provider will exercise all due skill, care and diligence and will periodically review the adequacy and appropriateness of any custodian where client assets are deposited. Your assets will be pooled with those of other clients, and as a result your holding may not be individually identifiable on the relevant company register. 2. A person who holds Securities may from time to time be invited to cast votes in relation to the company whose Securities those are, attend meetings of those companies, subscribe for additional Securities and/or to take other actions, all on account of the fact that that person is a holder of those Securities. These are sometimes referred to as “corporate actions”. The registered holder of those Securities will be informed of these corporate actions (i.e. the Custodian in this case). You hereby: (i) acknowledge and agree that we will have no duty to inform you of any corporate actions related to any Securities that are beneficially owned by you through our Services, even if we become aware thereof,
View Source

Related to Your Securities

  • Securities On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, the Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly, agrees to purchase from the Company, at the price set forth in Schedule B, the aggregate principal amount of Securities set forth in Schedule A opposite the name of such Underwriter, plus any additional principal amount of Securities which such Underwriter may become obligated to purchase pursuant to the provisions of Section 10 hereof.

  • Issued Securities All of Your issued and outstanding shares of Common Stock, Warrant Stock or any other securities have been duly authorized and validly issued and are fully paid and nonassessable. All outstanding shares of Common Stock and Warrant Stock were issued in full compliance with all Federal and state securities laws. In addition as of the Effective Date: Your authorized capital consists of (i) 105,608,000 shares of Common Stock, of which 12,027,455 shares of Common Stock are issued and outstanding, (ii) 14,100,000 shares of Series A Preferred Stock, of which 13,650,000 shares are issued and outstanding, (iii) 12,150,000 shares of Series B Preferred Stock, of which 11,803,284 shares are issued and outstanding, (iv) 9,000,000 shares of Series C Preferred Stock, of which 8,968,604 shares are issued and outstanding, (v) 10,700,000 shares of Series D Preferred Stock, of which 9,481,998 shares are issued and outstanding, (vi) 16,500,000 shares of Series E Preferred Stock, of which 11,342,180 shares are issued and outstanding, and (vii) 19,908,000 shares of Series F Preferred Stock, of which 18,061,055 shares are issued and outstanding. You have reserved 14,493,334 shares of Common Stock for issuance under Your Stock Incentive Plan, under which 7,264,503 options have been granted and are currently outstanding. You have warrants outstanding to purchase up to 424,342 shares of Series A Preferred Stock, 183,748 shares of Series D Preferred Stock, 4,468,854 shares of Series E Preferred Stock and 263,261 shares of Series F Preferred Stock. Except as otherwise provided in this Warrant Agreement and as noted above, there are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of Your capital stock or other of Your securities. Except as set forth in Your Eighth Amended and Restated Stockholders’ Rights Agreement dated as of October 29, 2010 (the “Stockholders’ Agreement”), a true, correct and complete copy of which has been delivered to Us prior to the issuance of this Warrant, Your stockholders do not have preemptive rights to purchase new issuances of Your capital stock.

  • Restrictions on Public Sale by Holders of Registrable Securities Each Holder of Registrable Securities agrees, if requested by the underwriters of an Underwritten Offering, to enter into a customary letter agreement with such underwriters providing such Holder will not effect any public sale or distribution of Registrable Securities during the 60 calendar day period beginning on the date of a prospectus or prospectus supplement filed with the Commission with respect to the pricing of any Underwritten Offering, provided that (i) the duration of the foregoing restrictions shall be no longer than the duration of the shortest restriction generally imposed by the underwriters on the Partnership or the officers, directors or any other Affiliate of the Partnership on whom a restriction is imposed and (ii) the restrictions set forth in this Section 2.07 shall not apply to any Registrable Securities that are included in such Underwritten Offering by such Holder. In addition, this Section 2.07 shall not apply to any Holder that is not entitled to participate in such Underwritten Offering, whether because such Holder delivered an Opt-Out Notice prior to receiving notice of the Underwritten Offering or because such Holder holds less than $15 million of the then-outstanding Registrable Securities.

  • Private Warrants On the Closing Date and the Option Closing Date, as applicable, the Private Warrants have been purchased as provided for in the Subscription Agreements and the purchase price for such securities shall be deposited into the Trust Account.

  • Restrictions on Transfer and Exchange of Global Securities Notwithstanding any other provisions of this Indenture, a Global Security may not be transferred as a whole except by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of such successor Depository.